Triethylamine → HCID 66845170, compound
Reaction equation
O[CH2:2][C@H:3]1[C:11]2[C:10]([N:12]3[CH2:17][CH2:16][N:15]([C:18]([O:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19])[CH2:14][CH2:13]3)=[N:9][CH:8]=[N:7][C:6]=2[CH2:5][CH2:4]1.[F:25]C(F)(S(F)(=O)=O)C(F)(F)C(F)(F)C(F)(F)F.F.F.F.C(N(CC)CC)C.C(N(CC)CC)C>O1CCCC1>[C:21]([O:20][C:18]([N:15]1[CH2:16][CH2:17][N:12]([C:10]2[C:11]3[C@H:3]([CH2:2][F:25])[CH2:4][CH2:5][C:6]=3[N:7]=[CH:8][N:9]=2)[CH2:13][CH2:14]1)=[O:19])([CH3:23])([CH3:22])[CH3:24]Participants
6
Procedure
(R)-tert-Butyl 4-(5-(hydroxymethyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate (30.0 mg, 0.0897 mmol) was dissolved in tetrahydrofuran (0.080 mL). Perfluoro-1-butanesulfonylfluoride (0.0644 mL, 0.359 mmol) and triethylamine trishydrofluoride (0.0584 mL, 0.359 mmol) were added to this solution, followed by triethylamine (0.150 mL, 0.726 mmol). The reaction mixture was allowed to stir for 12 hours at room temperature. The reaction was concentrated, and the material was subjected to chromatography on SiO2 and eluted with 10% MeOH/DCM. The desired 4-((R)-5-fluoromethyl-6,7-dihydro-5H-cyclopentapyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester (25.0 mg, 83%) was isolated. LC/MS (APCI)+ m/z 337.2.
Workup
- concentrationThe reaction was concentrated
- washeluted with 10% MeOH/DCM
Sources & evidence
- ORD record
- ord-d28a99cd52844744bcafd272e4ea534d
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09409886B2
Reaction notes
Loading…